skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Alopecia areata: a new treatment plan

Review

(2643) Views  (1252) Full article downloads

Authors: Alsantali A

Published Date July 2011 Volume 2011:4 Pages 107 - 115
DOI: http://dx.doi.org/10.2147/CCID.S22767

Adel Alsantali
Department of Dermatology, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia

Abstract: Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles. Unfortunately, none of these agents is curative or preventive. Also, many of these therapeutic agents have not been subjected to randomized, controlled trials, and, except for topical immunotherapy, there are few published studies on long-term outcomes. The treatment plan is designed according to the patient's age and extent of disease. In this paper, the therapeutic agents are organized according to their efficacy and safety profiles into first-line, second-line, and third-line options.

Keywords: alopecia areata, corticosteroids, immunotherapy, intralesional, phototherapy, sulfasalazine







Readers of this article also read:
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • American Acne and Rosacea Society

    The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.